On multivariate analysis of these significant factors, stratified by stage, only C-reactive protein (HR 2.89, 95% CI 1.42–5.91, P=0.004) and no adjuvant therapy (HR 0.29, 95% CI (0.14–0.62, P=0.001) was independently associated with poorer cancer-specific survival. Here, CRP is linked to cancer.